HUDSON EDGE INVESTMENT PARTNERS INC. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
HUDSON EDGE INVESTMENT PARTNERS INC. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q1 2023$486
+5.0%
13,482
+15.0%
0.15%
-4.4%
Q4 2022$463
-99.9%
11,7250.0%0.16%
-9.7%
Q3 2022$471,000
-4.5%
11,7250.0%0.18%
-2.8%
Q2 2022$493,000
+7.9%
11,7250.0%0.18%
+25.0%
Q1 2022$457,000
+2.9%
11,725
+5.2%
0.14%
+4.3%
Q4 2021$444,00011,1450.14%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders